Alzinova is a company headquartered in Sweden.
Alzinova AB is a Swedish clinical-stage biopharma company developing an active vaccine immunotherapy using proprietary AβCC Peptide™ technology to treat Alzheimer's disease.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.